CD274 and neoplasm: Specifically, the PD-L1/programmed death receptor 1 engagement leads to inhibitory outcomes, compromising T cell proliferation, survival, and cytokine production.[4] Tumor cells elude immunological scrutiny and perpetuate their proliferation, thereby fostering the genesis and evolution of neoplasms.